About 24% borderline diabetic, finds Neuberg Diagnostics study

  • Age group of 50 and above showed the highest prevalence of prediabetes
  • Second highest prediabetics are from 36 to 50 age group
  • Prevalence of prediabetes in male was about 25% whereas in female it was 23%

November 13, 2020: Neuberg Diagnostics, India’s fourth largest diagnostic chain, conducted a study on the prevalence of prediabetes in five cities viz. Ahmedabad (Neuberg Supratech), Bangalore (Neuberg Anand), Chennai (Neuberg Ehrlich), Kochi (Neuberg Diagnostics) and Hyderabad (Neuberg Diagnostics). The study assessed 453,854 fasting blood sugar test samples across age groups collected between October 2018 and October 2020. The results indicated that across age groups, 24% of the people had borderline levels of blood sugar i.e. were prediabetic.

The highest prevalence was observed among those over 50 years age at 68%; followed by 36 to 50 years of age group at 24%. The prevalence among those less than 35 years of age group was 8%.

Dr. Sandip Shah, Executive Director, Neuberg Diagnostics said, “Every person today is at risk of having or developing diabetes, but the only way to know this is through regular monitoring of blood sugar levels. Lately, we have seen that people consider body mass index (BMI) as the ultimate benchmark for their health status but even people with balanced BMI can have diabetes. We have seen a healthy looking individual with borderline diabetes. So clearly, healthy lifestyle is not an indicator of absence of diabetes.”

He added, “Genetics influence the propensity of people having borderline diabetes. We encourage parents with diabetes to ensure that their children keep check of their sugar levels right from the age of 18. Parents should be watchful of other symptoms in younger children. Early detection of pre-diabetes can enable them to prevent it.”

Dr. Sujay Prasad, Medical Director, Neuberg Diagnostics said, “Before becoming a diabetic, a healthy person goes through a stage of prediabetes. This stage could be a few months to couple of years depending on lifestyle and diet. During prediabetes stage, blood sugar is elevated, but not enough to satisfy the international criteria for diabetes. This awareness will help persons with prediabetes to manage their sugar levels and prevent becoming diabetic. Regular monitoring through health checks is a sure way of becoming aware if one is a prediabetic and prevent progression to diabetes.”

Study found that about 0.32% of prediabetics were from 0-18 age group.On this, Dr. Prasad added, “Prediabetes can develop at any age however with advance age, the risk becomes higher.”

Ms Aishwarya Vasudevan, Group Chief Operating Officer, Neuberg Diagnostics said, “Our study implies that there is need for continuous awareness on diabetes and pre-diabetes. Diabetes is the leading silent disease world over. With awareness, timely diagnosis & treatment, and the right changes in diet & lifestyle, prediabetes can be reversed, and diabetes can be prevented.”  

For this study, the standard fasting blood sugar test value between 100 to 125 was considered as prediabetics.

City Today News

(citytoday.media)

9341997936

Fanzart Launches Ultra-Luxurious Champagne Gold-Plated Fandelier

Bengaluru, November 12, 2020: Fanzart, India’s foremost creators of luxury fans launched their ultra-luxurious Champagne Gold Fandelier (fan and chandelier) with their patented high vortex blades and pure gold plating, at a press conference here today.

Speaking on the launch of the Champagne Gold Fandelier, Anil Lala, Founder and Managing Director, Fanzart says, “The Champagne Gold fan is an exclusive fandelier for the discerning few. Spending more time at home is the new norm considering the ongoing situation in the world. Comfort coupled with good looks is expected of functional décor elements such as fandeliers. The Champagne Gold Fandelier offers silent, yet efficient cooling with its patented vortex blades that displace 8000 cubic feet per minute (CFM) of air and comes with a Brushless DC Motor (BLDC motor). Our unique summer-winter feature makes this an ideal option for dining rooms and during winters when air circulation is a priority over cooling. The fan uses only 22 watts of electricity, making it power-efficient as well”.

Perfect match for several interior mood boards: This 3-blade, remote controlled fan, comes with a light kit, offering multiple illumination options. The regal champagne gold colour makes it a perfect match for several interior mood boards – Neo-Classic, Eclectic, Hollywood Glam, Victorian and Bohemian among others. The fandelier also comes with Fanzart’s unique summer- winter feature – that combines clockwise and anti-clockwise movements to provide a cool breeze and cosy warm air effect. This makes the fan ideal for placement above dining tables. It can also be placed in living rooms, drawing rooms, family areas, walk- in wardrobes, and other spaces.

Speaking on the design of the Champagne Gold Fandelier, Tarun Lala, Executive Director, Fanzart says, “Besides seamless functioning, we have placed intense focus on the looks of the fandelier. The Champagne Gold colour makes it an easy match to most interior design themes and colour palettes. The gold plating gives it a chic and luxurious touch. The lighting strips offer LEDS in warm light, daylight, and white light options match the user’s needs. All three options come with a dimmer option. This functional décor elements fits perfectly in most interior design schemes”. Fanzart’s Champagne Gold Fandelier is priced at Rs 1.50 lakh and will be available at https://www.fanzartfans.com or 78 showroom locations across India.

Technical Details

*Chandelier fan (non-crystal) *Patented Vortex Blades 8000 CFM. *Bright LED strip with 3 colours of LED – Warm light, Day light, White light with dimmer. *Powered by Brushless DC motor (BLDC motor). Absorbs only 22 watts of power. *High-quality remote control for convenience. *Blade Material – 3 blades, 5D Vortex ABS *Blade Mechanism – Regular *Blade Size -22 inches *Sweep – 558 mm / 22 in *Motor Spec – 153 x 12 mm DC *Height of Fan: 559 mm / 22 in *Additional features: Summer Winter Feature

City Today News

(citytoday.media)

9341997936

Gland Pharma IPO – IPO price band fixed at Rs 1490 to Rs 1500 per equity share

Gland Pharma IPO :-

Gland Pharma issue oversubscribed by 2.05 times

Rs 6480-crore issue is the largest in pharma industry

Gland Pharma raised Rs 1943.86 crore from Anchor Investors

Gland Pharma allocates 12,959,089 equity shares at the upper price band of Rs 1500 per equity shares to anchor investors

70 marquee global and domestic funds came in as anchor investors

IPO price band fixed at Rs 1490 to Rs 1500 per equity share

Gland Pharma to raise Rs 6,480 crore through the IPO

IPO include Rs 1,250 crore fresh issue and the rest being Offer for Sale

Gland Pharma to use Rs 1,250 crore fresh funds for capital expenditure & working capital requirements

Gland Pharma is an integrated manufacturer of complex injectable products

City Today News

(citytoday.media)

9341997936

Meenakshi Mission Hospital launches Diabetic Home Care that provides consultation and routine checkup services at patient’s residence

Diabetes Management Critical to Reducing Covid-19 Mortality Rate: Medical Expert

●     82% of people who died of Covid-19 in India had a comorbidity

●     Nearly 70% of the dead had diabetes as a comorbidity

●     Covid-19 infection can make a healthy person diabetic

●     Meenakshi Mission Hospital launches Diabetic Home Care that provides consultation and routine checkup services at patient’s residence

11 November 2020:  “Keeping Diabetes Mellitus under control is the best healthcare strategy available for diabetic patients in the time of Covid-19 pandemic, as over 70% of the people who succumbed to the infection in India either had diabetes or both diabetes and hypertension,” said Dr. C. R. Mahesh Babu, Consultant, Department of Diabetology, Meenakshi Mission Hospital and Research Centre. He added that it is estimated that about 50% of the diabetic patients who lost their lives to Covid had poorly managed diabetes.

Citing reports, Dr Babu pointed out that Covid-19 is found to have the potential to induce diabetes in healthy people. Hence it is important that the healthy individuals strictly follow personal hygiene, social distancing, and other Covid-19 guidelines to protect themselves from getting infected, and from becoming vulnerable to diabetes.

Dr Babu was addressing a Press Conference, organised as part of the World Diabetes Day 2020, which falls on November 14 every year. The event also marked the launch of Diabetic Home Care package of Meenakshi Mission Hospital. The package offers consultations and services of diabetologists, physicians, specialists, physiotherapists, dieticians, and paramedical staff at the residences of patients. It also includes routine investigations such as urine analysis, fasting lipid profile, liver function test, renal function test and thyroid function test.

Dr Babu said that diabetes is one of the most common chronic comorbidities across the globe – and more so in India. About 82% of the Covid-19 deaths in India were linked to comorbidities such as Diabetes Mellitus, hypertension, and obesity – with diabetes being the single largest contributor. Better management of diabetes alone could have saved a significant number of lives lost.

He informed the media that Covid-19 infection could not only worsen the status of existing diabetic conditions, but it can also lead to the onset of diabetes. Though exactly how Covid-19 infection makes people diabetic is not established clearly, the medical community believes that it was the result of the damage caused by the infection to the pancreatic beta cells, which in turn compromise the secretion of insulin.

Another hypothesis is that the intensive steroid therapy given to the Covid-19 patients to modulate the immune system could cause the development of diabetes.

Dr Babu opined that the pandemic has shown the public the importance of personal hygiene, immunity, and the need to keep chronic lifestyle diseases like diabetes, hypertension, and obesity at bay by following necessary lifestyle modifications, and, in the case of diabetic patients, the need to keep diabetes under control.

He said that there are over 77 million diabetic patients in India, and the prevalence of the condition is increasing at an alarming rate. However, For every person diagnosed with diabetes there remains one who goes undetected. In Tamil Nadu, the prevalence of diabetes in urban areas is to the tune of 15-18% and in rural areas, 6-8%.

Among the major causes of diabetes are lack of exercise, stress, wrong food (especially the excessive intake of white sugar, refined rice, refined wheat, and processed food), obesity – especially around the waist, and lifestyle changes.

Dr Babu stressed on the need for the early detection of the disease that seldom shows any symptoms of its presence until the condition becomes very severe. To improve the rate of detection people should attend screening camps even if they do not have symptoms. Timely identification and diagnosis are important for early treatment and better sugar control.

Meenakshi Mission Hospital launches Diabetic Home Care that provides consultation and routine checkup services at patient’s residence Please contact for appointment: 7708353777 / 73588 88222

City Today News

(citytoday.media)

9341997936

Nippon Paint launches ATOM FIBRA, a revolutionary multipurpose emulsion

*2-in-1 multi-purpose emulsion designed for both interior & exterior walls
*Reinforced micro fibers to suit multi-climate conditions at affordable price

Bengaluru, November 9th 2020 : Nippon Paint (India) Private Limited (Decorative Division) Asia Pacific’s leading paint manufacturer today launched ATOM FIBRA, a 2-in-1 multi-purpose emulsion specially designed for both interior & exterior walls offering the best protection at affordable price. The innovative paint was launched today by Mr. Padasalgi Vinay Jayateerthi – GM (Sales) Karnataka, Decorative Paint, Nippon Paint (India). They were also joined by actress Sreeleela Das who attended the event which was held at Vivanta by Taj, Bengaluru and unveiled the new product.
The ATOM FIBRA is a breakthrough emulsion that is reinforced with micro fibers giving enhanced mechanical strength to the paint. Its disruptive technology is ideal for both interior as well as exterior wall surfaces. The paint comes with a 4-year performance warranty* and is formulated with reinforced microfibers that provides superior strength. The paint further comes with Anti-Carbonation technology, excellent coverage feature and better washability thereby giving a smooth finish to the walls.
Emphasizing the need for such a breakthrough product in the market, Mr. Mahesh S. Anand, President (Decorative Paint), Nippon Paint India commented, “Nippon Paint is synonymous in industry for introducing revolutionary the paint products and innovative services. ATOM FIBRA was conceptualized keeping in mind the demands of the modern customer looking for a multi-purpose emulsion that is efficient for both interiors as well as exteriors. We wish to offer our customers a paint that gives

excellent protection and durability, while being affordable at the same time. The ATOM FIBRA has been backed by years of market research and market learnings. We are optimistic that the new paint will find a lot of takers in the market owing to its affordability and functionality.”

Amidst a gradually recovering market, Nippon Paint’s ATOM FIBRA, will be commercially available in the market through Nippon Paint’s select dealer partners. To learn more about Nippon’s ATOM FIBRA, visit http://www.nipponpaint.co.in/

City Today News

(citytoday.media)

9341997936